HomeMDGL • NASDAQ
add
Madrigal Pharmaceuticals Inc
Previous close
$194.38
Day range
$189.00 - $195.58
Year range
$119.76 - $322.67
Market cap
4.05B USD
Avg Volume
574.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 117.18M | 37.37% |
Net income | -112.19M | -30.60% |
Net profit margin | — | — |
Earnings per share | -5.68 | -14.06% |
EBITDA | -117.03M | -37.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 634.13M | 76.75% |
Total assets | 640.55M | 76.67% |
Total liabilities | 235.21M | 42.40% |
Total equity | 405.33M | — |
Shares outstanding | 19.90M | — |
Price to book | 9.53 | — |
Return on assets | -66.69% | — |
Return on capital | -88.59% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -112.19M | -30.60% |
Cash from operations | -79.93M | -36.60% |
Cash from investing | -362.12M | -645.47% |
Cash from financing | 479.92M | 81.55% |
Net change in cash | 37.86M | -86.09% |
Free cash flow | -42.17M | -53.80% |
About
Founded
2011
Headquarters
Website
Employees
376